GlaxoSmithKline Pharmaceuticals Limited — Others, 11-02-2025: Action(s) taken or orders passed

GlaxoSmithKline Pharmaceuticals Limited has received an order from the Additional Commissioner Adjudication, Delhi-North, demanding a total of ₹2.19 crore, consisting of ₹1.09 crore in tax and a ₹1.09 crore penalty related to disallowed transitional credit for the period from July 2017 to March 2018. While the company is currently evaluating the demand order, it anticipates no impact on financial operations. Investors may view this development as a neutral impact, given the company's proactive stance on addressing the issue without immediate consequences on financial health.